Andersen Eric

Avg. Two Year Performance

No purchase track record

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	40%	43%	77%	6%	0%
Purchase Success Rate	3 of 5	3 of 5	3 of 5	1 of 5	0 of 5
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Merrimack Pharmaceuticals, ...

Drugs » Biotechnology

Director:

Holdings: 534.01K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--